ADAR1 inhibitor

This page covers all ADAR1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ADAR1 (Adenosine Deaminase Acting on RNA 1).

Targets

ADAR1 (Adenosine Deaminase Acting on RNA 1)

Phase 3 pipeline (1)

• ADX-324 Dose Level 2 · ADARx Pharmaceuticals, Inc. · Oncology
  ADX-324 is an ADAR1 inhibitor that modulates RNA editing to enhance innate immune responses against cancer.

Patent intelligence

• adar1 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates